Implementation Trial In patieNts With rEnal failuRe and diAbetes for Major Adverse reNal and Cardiovascular Events

The goal of this clinical study is to establish if the use of public health-related messages, designed and disseminated to a targeted population, will result in tangible improvements in patient outcomes and healthcare practices. Specific health-related messages oriented towards patients, through their biological results and HealthCare Professionals (HCPs), will be sent to participants included in the intervention group. The control group will not receive any health-related message (routine care). The aim is to evaluate if this intervention leads to differences in Major Adverse Renal and Cardiovascular Events (MARCE), compared to routine care (no dissemination of health messages) in patients suffering in diabetes and renal failure.

NCT Number	NCT07634718
Lead Sponsor	Nantes University Hospital Collaborators: Hospices Civils de Lyon, University Hospital, Toulouse, University Hospital, Tours, Biogroup Laboratoire de biologie médicale, Santé publique France-InVS (Institut National de Veille sanitaire)
Conditions	Diabetes, Renal Failure , Chronic
Enrollment	125,000 participants
Start Date	2026-06
Primary Completion	2029-06 (estimated)
Study Completion	2032-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-09